Literature DB >> 22921471

Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice.

Deborah Chiabrando1, Veronica Fiorito, Samuele Marro, Lorenzo Silengo, Fiorella Altruda, Emanuela Tolosano.   

Abstract

Ferroportin (FPN), the sole characterized iron exporter, is mainly controlled by the peptide hormone hepcidin in response to iron, erythroid factors, hypoxia, and inflammation. In addition, intracellular iron level controls FPN translation by modulating the binding of Iron Responsive Proteins at the 5'UTR of FPN mRNA. Recently, hypoxia inducible factor (HIF)2α has been shown to regulate FPN expression in intestinal cells. Here we show that, during experimentally-induced acute anemia in mice, FPN is regulated at transcriptional level in a cell-specific manner. FPN mRNA level increases in duodenum and spleen macrophages, whereas it does not change in liver and is strongly down-regulated in erythroid precursors. These results were confirmed in Caco2, Raw264.7 and K562 cells treated with a hypoxic stimulus. Moreover, we found a differential expression of HIF1α and HIF2α in cells and tissues that might account for the specificity of FPN regulation. Thus, hypoxia, by directly controlling hepcidin and its target FPN, orchestrates a complex regulatory network aimed at ensuring rapid iron recovery from the periphery and efficient iron utilization in the erythroid compartment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921471     DOI: 10.1016/j.bcmd.2012.08.002

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  9 in total

1.  The commensal bacterium Bacteroides fragilis down-regulates ferroportin expression and alters iron homeostasis in macrophages.

Authors:  Smriti Verma; Rachel Prescott; Bobby J Cherayil
Journal:  J Leukoc Biol       Date:  2019-06-05       Impact factor: 4.962

2.  The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation.

Authors:  Deborah Chiabrando; Samuele Marro; Sonia Mercurio; Carlotta Giorgi; Sara Petrillo; Francesca Vinchi; Veronica Fiorito; Sharmila Fagoonee; Annalisa Camporeale; Emilia Turco; Giorgio R Merlo; Lorenzo Silengo; Fiorella Altruda; Paolo Pinton; Emanuela Tolosano
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

3.  Lack of Plasma Protein Hemopexin Results in Increased Duodenal Iron Uptake.

Authors:  Veronica Fiorito; Simonetta Geninatti Crich; Lorenzo Silengo; Silvio Aime; Fiorella Altruda; Emanuela Tolosano
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 4.  "Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels.

Authors:  Manfred Nairz; Igor Theurl; Filip K Swirski; Guenter Weiss
Journal:  Pflugers Arch       Date:  2017-03-01       Impact factor: 3.657

5.  Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.

Authors:  Xingkang Jiang; Changwen Zhang; Shiyong Qi; Shanqi Guo; Yue Chen; E Du; Hongtuan Zhang; Xiaoming Wang; Ranlu Liu; Baomin Qiao; Kuo Yang; Zhihong Zhang; Yong Xu
Journal:  Oncotarget       Date:  2016-12-20

Review 6.  Iron Regulation: Macrophages in Control.

Authors:  Nyamdelger Sukhbaatar; Thomas Weichhart
Journal:  Pharmaceuticals (Basel)       Date:  2018-12-14

7.  Phytoestrogens modulate hepcidin expression by Nrf2: Implications for dietary control of iron absorption.

Authors:  Henry K Bayele; Sara Balesaria; Surjit K S Srai
Journal:  Free Radic Biol Med       Date:  2015-11-10       Impact factor: 7.376

Review 8.  The Functional Versatility of Transferrin Receptor 2 and Its Therapeutic Value.

Authors:  Antonella Roetto; Mariarosa Mezzanotte; Rosa Maria Pellegrino
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-23

9.  Therapeutic effect of a histone demethylase inhibitor in Parkinson's disease.

Authors:  Ming-Dao Mu; Zhong-Ming Qian; Sheng-Xi Yang; Kang-Lin Rong; Wing-Ho Yung; Ya Ke
Journal:  Cell Death Dis       Date:  2020-10-28       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.